-
Signature
-
/s/ Kyle Pilkington, Attorney-in-Fact
-
Issuer symbol
-
SES
-
Transactions as of
-
15 Dec 2025
-
Net transactions value
-
-$182,823
-
Form type
-
4
-
Filing time
-
16 Dec 2025, 17:30:05 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Gan Hong |
CHIEF SCIENCE OFFICER |
C/O SES AI CORPORATION, 35 CABOT ROAD, WOBURN |
/s/ Kyle Pilkington, Attorney-in-Fact |
16 Dec 2025 |
0001907008 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SES |
Class A Common Stock |
Options Exercise |
$13,992 |
+93,277 |
+7.4% |
$0.1500 |
1,346,563 |
15 Dec 2025 |
Direct |
F1, F2 |
| transaction |
SES |
Class A Common Stock |
Options Exercise |
$1,076 |
+6,723 |
+0.5% |
$0.1600 |
1,353,286 |
15 Dec 2025 |
Direct |
F1, F2 |
| transaction |
SES |
Class A Common Stock |
Sale |
$197,890 |
-100,000 |
-7.4% |
$1.98 |
1,253,286 |
15 Dec 2025 |
Direct |
F1, F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SES |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-93,277 |
-100% |
$0.000000 |
0 |
15 Dec 2025 |
Class A Common Stock |
93,277 |
$0.1500 |
Direct |
F1, F4 |
| transaction |
SES |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-6,723 |
-0.57% |
$0.000000 |
1,179,832 |
15 Dec 2025 |
Class A Common Stock |
6,723 |
$0.1600 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: